Skip to content

MIRL

Immunology/HematologyHematologicImmune

Summary

MIRL (Membrane Inhibitor of Reactive Lysis), also known as CD59, is a GPI-anchored complement regulatory protein found on host cell membranes. It protects cells from complement-mediated lysis by inhibiting the formation of the membrane attack complex (MAC). Deficiency of CD59 (along with DAF/CD55) is the underlying cause of paroxysmal nocturnal hemoglobinuria (PNH).

Detail

MIRL/CD59 functions by binding to C8 and C9 components of the complement cascade, preventing the polymerization of C9 and thus blocking formation of the membrane attack complex (C5b-9). This protects host cells from autologous complement-mediated lysis. CD59 is anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor, similar to another complement regulatory protein, Decay-Accelerating Factor (DAF/CD55), which inhibits C3 and C5 convertases.

In paroxysmal nocturnal hemoglobinuria (PNH), an acquired somatic mutation in the PIGA gene (X-linked, located on hematopoietic stem cells) impairs synthesis of the GPI anchor. This results in deficient surface expression of GPI-anchored proteins, including CD55 and CD59, on blood cells (especially RBCs). Without these protective proteins, red blood cells become susceptible to complement-mediated intravascular hemolysis, particularly during physiologic acidosis (e.g., during sleep, hence 'nocturnal').

Clinical features of PNH include intravascular hemolytic anemia, hemoglobinuria (classically dark urine in the morning), thrombosis (including unusual sites like hepatic or portal veins - Budd-Chiari syndrome), and increased risk of progression to acute myeloid leukemia or aplastic anemia. Diagnosis is made via flow cytometry showing decreased CD55 and CD59 on blood cells. Treatment includes eculizumab or ravulizumab, monoclonal antibodies that inhibit C5, preventing MAC formation and reducing hemolysis.

Understanding MIRL/CD59 is high-yield for USMLE Step 1 as it connects complement biology, GPI-anchor biochemistry, and the clinical presentation of PNH, a classic boards topic.

Sources

  • First Aid for the USMLE Step 1
  • Robbins Basic Pathology
  • Kaplan Immunology Lecture Notes

Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.

Related immunology/hematology terms

MIRL — Medical Glossary